selegiline has been researched along with fenfluramine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Donnelly, M; Ismond, D; Rapoport, JL; Zametkin, A | 1 |
| DuMontier, G; Jeng, I; Soblosky, JS | 1 |
| Adler, L; Huether, G; Poeggeler, B; Rüther, E | 1 |
| Fisher, H; Halladay, AK; Hesse, K; Kirschner, E; Wagner, GC | 1 |
1 review(s) available for selegiline and fenfluramine
| Article | Year |
|---|---|
New drug trials in attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; Desipramine; Dextroamphetamine; Double-Blind Method; Fenfluramine; Humans; Male; Selegiline; Tranylcypromine | 1985 |
1 trial(s) available for selegiline and fenfluramine
| Article | Year |
|---|---|
New drug trials in attention deficit disorder.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clinical Trials as Topic; Clorgyline; Desipramine; Dextroamphetamine; Double-Blind Method; Fenfluramine; Humans; Male; Selegiline; Tranylcypromine | 1985 |
6 other study(ies) available for selegiline and fenfluramine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
Topics: 5-Hydroxytryptophan; Animals; Binding Sites; Brain; Chick Embryo; Clorgyline; Fenfluramine; Mice; Monoamine Oxidase Inhibitors; Pargyline; Rats; Selegiline; Serotonin | 1985 |
Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Fenfluramine; Fluoxetine; Injections, Intraperitoneal; Male; Melatonin; Pargyline; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin Receptor Agonists; Tryptophan | 1993 |
Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Methyltyrosine; Animals; Clorgyline; Corpus Striatum; Dopamine; Drug Interactions; Fenclonine; Fenfluramine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Selegiline; Serotonin; Serotonin Antagonists; Tryptophan | 2001 |